Oral contraceptives and invasive adenocarcinomas and adenosquamous carcinomas of the uterine cervix

American Journal of Epidemiology

Volumn 144, Issue 3, 1996, Pages 281-289

  Thomas, David B ^a   Ray, Roberta M ^a   Berry, Geoffrey ^b   MacLennan, Robert ^b   Shearman, Rodney ^b   Jelihovsky, Tatiana ^b   Booth, Joan Cooper ^b   Molina, Ramiro ^o   Martinez, Luis ^o   Salas, Oriana ^o   Dabancens, Alfredo ^o   Cuadros, Alvaro ^c   Aristizabal, Nubia ^c   Modan, Baruch ^d   Ron, Elaine ^d   Alfandary, Esther ^d   Mati, J G ^e   Kenya, Patrick ^e   Kungu, Alfred ^e   Gatei, D ^e   Cuevas, Hector Rodriguez ^f   Salazar, Socorro Benavides ^f   Palet, Antonio ^f   Ontiveros, Patricia ^f   Apelo, Ruben A ^g   De La Cruz, Julietta R ^g   Baens, Jose ^g   Canlas Jr , Benjamin D ^g   Silpisornkosol, Suporn ^h   Pardthaisong, Tieng ^h   Charoeniam, Viruch ^h   Theetranont, Choti ^h   Boosiri, Banpot ⁱ   Chutivongse, Supawat ⁱ   Virutamasen, Pramuan ⁱ   Wongsrichanalai, Chansuda ⁱ   Sindhavananda, Sermsri ⁱ   Koetsawang, Suporn ^j   Rachawat, Duangdao ^j   Koetsawang, Amorn ^j   Riotton, Gustave ^k   Christopherson, William M ^l   Melnick, Joseph L ^m   Adam, Ervin ^m   Meirik, Olav ⁿ   Farley, Timothy M M ⁿ   Holck, Susan ⁿ   more..

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF SYDNEY   (Australia)

^c Hospital Universitario   (Colombia)

^d SHEBA MEDICAL CENTER   (Israel)

^e UNIVERSITY OF NAIROBI   (Kenya)

^f HOSPITAL GENERAL DE MÉXICO   (Mexico)

^g UNIVERSITY OF THE PHILIPPINES MANILA   (Philippines)

^h Faculty of Medicine Chiang Mai University   (Thailand)

ⁱ CHULALONGKORN UNIVERSITY   (Thailand)

^j MAHIDOL UNIVERSITY   (Thailand)

^k UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^l University of Louisville School of Medicine   (United States)

^m BAYLOR COLLEGE OF MEDICINE   (United States)

ⁿ WORLD HEALTH ORGANIZATION   (Switzerland)

^o NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADENOCARCINOMA; ADENOSQUAMOUS CARCINOMA; ADULT; AGE; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; ORAL CONTRACEPTION; ORAL DRUG ADMINISTRATION; UTERINE CERVIX CARCINOMA;

EID: 9544242825     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a008923     Document Type: Article

References (26)

1. Peters RK, Chao A, Mack TM, et al. Increased frequency of adenocarcinoma of the uterine cervix in young women in Los Angeles County. J Natl Cancer Inst 1986;76:423-8.
2. Schwartz SM, Weiss NS. Increased incidence of adenocarcinoma of the cervix in young women in the United States. Am J Epidemiol 1986;124:1045-7.
3. Devesa SS, Young JL Jr, Brinton LA, et al. Recent trends in cervix uteri cancer. Cancer 1989;64:2184-90.
4. Ursin G, Peters RK, Henderson BE, et al. Oral contraceptive use and adenocarcinoma of cervix. Lancet 1994;344:1390-4.
5. Eide TJ. Cancer of the uterine cervix in Norway by histologic type, 1970-84. J Natl Cancer Inst 1987;79:199-205.
6. Chilvers C, Mant D, Pike MC. Cervical adenocarcinoma and oral contraceptives. Br Med J 1987;295:1446-7.
7. Dallenbach-Hellweg G. On the origin and histological structure of adenocarcinoma of the endocervix in women under 50 years of age. Pathol Res Pract 1984;179:38-50.
8. Silcocks PBS, Thornton-Jones H, Murphy M. Squamous and adenocarcinoma of the uterine cervix: a comparison using routine data. Br J Cancer 1987;55:321-5.
9. Persson E, Einhorn N, Pettersson F. A case-control study of oral contraceptive use in women with adenocarcinoma of the uterine cervix. Eur J Obstet Gynecol Reprod Biol 1987;26: 85-90.
10. Horowitz IR, Jacobson LP, Zucker PK, et al. Epidemiology of adenocarcinoma of the cervix. Gynecol Oncol 1988;31:25-31.
11. Jones MW, Silverberg SG. Cervical adenocarcinoma in young women: possible relationship to microglandular hyperplasia and use of oral contraceptives. Obstet Gynecol 1989;73: 984-9.
12. Parazzini F, La Vecchia C, Negri E, et al. Risk factors for adenocarcinoma of the cervix: a case-control study. Br J Cancer 1988;57:201-4.
13. Brinton LA, Huggins GR, Lehman HF, et al. Long-term use of oral contraceptives and risk of invasive cervical cancer. Int J Cancer 1986;38:339-44.
14. Brinton LA, Reeves WC, Brenes MM, et al. Oral contraceptive use and risk of invasive cervical cancer. Int J Epidemiol 1990;19:4-11.
15. Brinton LA, Tashima KT, Lehman HF, et al. Epidemiology of cervical cancer by cell type. Cancer Res 1987;47:1706-11.
16. World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives. Invasive squamous-cell cervical carcinoma and combined oral contraceptives: results from a multinational study. Int J Cancer 1993;55:228-36.
17. Histological typing of female genital-tract tumors. In: Poulsen HE, Taylor DW, Sobin LH, eds. International classification of tumors. Geneva: World Health Organization, 1975.
18. Dreesman GR, Matson DO, Courtney RJ, et al. Detection of herpes virus type-specific antibody by a microsolid-phase radioimmunometric assay. Intervirology 1979;12:115-19.
19. Breslow NE, Day NE. Statistical methods in cancer research. Vol 1. The analysis of case-control studies. IARC scientific publications no. 32. Lyon: IARC, 1980.
20. Rosenblatt KA, Thomas DB, and the WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Hormonal content of combined oral contraceptives in relation to the reduced risk of endometrial carcinoma. Int J Cancer 1991;49: 870-4.
21. Schifffman MH, Bauer HM, Hoover RN, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993;85:958-64.
22. Bjersing L, Khama R, Evander M, et al. HPV 18 and cervical adenocarcinomas. Anticancer Res 1991;11:123-8.
23. Das BC, Gopalkrishna V, Das DK, et al. Human papilloma virus DNA sequences in adenocarcinoma of the uterine cervix in Indian women. Cancer 1993;72:147-53.
24. Bosch FX, Munoz N, de Sanjose S, et al. Risk factors for cervical cancer in Colombia and Spain. Int J Cancer 1992;52: 750-8.
25. Masood S, Rhatigan RM, Wilkinson EW, et al. Expression and prognostic significance of estrogen and progesterone receptors in adenocarcinoma of the uterine cervix: an immunocytochemical study. Cancer 1993;72:511-18.
26. Pater A, Bayatpur M, Pater MM. Oncogenic transformation by human papilloma virus type 16 deoxyribonucleic acid in the presence of progesterone or progestins from oral contraceptives. Am J Obstet Gynecol 1990;162:1099-1103.